Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China flag China · Delayed Price · Currency is CNY
40.99
+0.56 (1.39%)
Feb 27, 2026, 3:00 PM CST

SHA:603392 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
51,82789,14195,280114,799134,45987,383
Market Cap Growth
-40.29%-6.44%-17.00%-14.62%53.87%-
Enterprise Value
47,25684,10590,027108,497134,05286,784
Last Close Price
40.9970.4674.7889.12107.3769.72
PE Ratio
-839.0976.3724.2466.52129.07
Forward PE
-48.6417.2920.4776.2197.59
PS Ratio
28.8639.7017.2910.2623.3837.12
PB Ratio
4.227.167.409.1429.4733.86
P/TBV Ratio
4.607.597.829.5332.2037.55
P/FCF Ratio
--251.9635.85212.031123.62
P/OCF Ratio
314.92251.0461.9627.7879.94186.63
EV/Sales Ratio
26.3237.4616.349.7023.3136.86
EV/EBITDA Ratio
--57.0020.0957.44107.25
EV/EBIT Ratio
--66.0020.6159.91119.75
EV/FCF Ratio
-82.13-238.0733.88211.391115.90
Debt / Equity Ratio
0.030.030.020.020.060.03
Debt / EBITDA Ratio
--0.190.050.120.10
Debt / FCF Ratio
--0.820.090.451.00
Net Debt / Equity Ratio
-0.39-0.40-0.43-0.55-0.30-0.28
Net Debt / EBITDA Ratio
11.0076.78-3.52-1.28-0.59-0.91
Net Debt / FCF Ratio
8.279.39-14.71-2.16-2.16-9.46
Asset Turnover
0.120.150.350.961.090.83
Inventory Turnover
1.120.981.221.641.711.49
Quick Ratio
3.763.723.343.201.671.86
Current Ratio
4.264.163.863.501.962.39
Return on Equity (ROE)
-2.70%0.86%9.80%56.79%58.22%32.77%
Return on Assets (ROA)
-3.04%-1.30%5.34%28.27%26.51%15.98%
Return on Invested Capital (ROIC)
-9.36%-4.27%18.83%103.82%79.47%41.71%
Return on Capital Employed (ROCE)
-5.70%-2.50%10.50%41.30%47.80%27.10%
Earnings Yield
-0.64%0.12%1.31%4.13%1.50%0.78%
FCF Yield
-1.11%-0.60%0.40%2.79%0.47%0.09%
Dividend Yield
--0.43%0.80%0.09%0.13%
Payout Ratio
-386.11%72.73%2.69%5.58%0.24%
Buyback Yield / Dilution
-3.21%-5.37%-0.86%-1.55%-2.96%-8.71%
Total Shareholder Return
-3.21%-5.37%-0.43%-0.75%-2.87%-8.59%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.